| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
69,867 |
62,164 |
$2.59M |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
5,637 |
5,408 |
$773K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
8,589 |
8,450 |
$708K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
18,412 |
15,804 |
$592K |
| 99215 |
Prolong outpt/office vis |
7,622 |
7,135 |
$401K |
| 36475 |
|
324 |
256 |
$349K |
| 93224 |
|
6,497 |
6,378 |
$299K |
| 93880 |
|
5,178 |
5,075 |
$275K |
| 93015 |
|
4,928 |
4,845 |
$204K |
| 93970 |
|
3,014 |
2,970 |
$187K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,809 |
1,800 |
$126K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
3,571 |
3,372 |
$102K |
| 93000 |
|
14,278 |
13,748 |
$99K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
4,226 |
1,219 |
$75K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
3,127 |
2,653 |
$75K |
| 99205 |
Prolong outpt/office vis |
969 |
940 |
$71K |
| 93923 |
|
2,005 |
1,977 |
$71K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
662 |
659 |
$52K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
403 |
399 |
$38K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,182 |
339 |
$38K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,023 |
1,708 |
$35K |
| 95806 |
|
314 |
307 |
$32K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,439 |
1,368 |
$28K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
1,138 |
365 |
$19K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
408 |
398 |
$16K |
| 93458 |
|
177 |
171 |
$15K |
| 93971 |
|
342 |
283 |
$12K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
2,370 |
696 |
$11K |
| 93978 |
|
305 |
303 |
$11K |
| J1245 |
Injection, dipyridamole, per 10 mg |
1,780 |
1,703 |
$9K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
850 |
802 |
$9K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
76 |
76 |
$9K |
| 3008F |
|
65,125 |
57,847 |
$8K |
| 97162 |
|
399 |
381 |
$8K |
| 93018 |
|
1,490 |
1,411 |
$7K |
| J0280 |
Injection, aminophyllin, up to 250 mg |
2,156 |
2,035 |
$6K |
| 93925 |
|
124 |
116 |
$5K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
2,252 |
650 |
$5K |
| J2785 |
Injection, regadenoson, 0.1 mg |
385 |
307 |
$4K |
| 93350 |
|
28 |
27 |
$3K |
| 93784 |
|
195 |
192 |
$3K |
| 94010 |
|
312 |
299 |
$3K |
| 93924 |
|
78 |
76 |
$3K |
| 99222 |
Initial hospital care, per day, moderate complexity |
83 |
80 |
$3K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
27 |
27 |
$2K |
| 99223 |
Prolong inpt eval add15 m |
39 |
39 |
$2K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
757 |
707 |
$2K |
| 99443 |
|
42 |
38 |
$2K |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
86 |
85 |
$1K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
12 |
12 |
$1K |
| 76706 |
|
65 |
64 |
$1K |
| 95811 |
|
14 |
14 |
$1K |
| 99407 |
|
126 |
108 |
$975.52 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
115 |
108 |
$846.91 |
| 82962 |
|
1,771 |
1,472 |
$748.34 |
| 93922 |
|
30 |
30 |
$677.45 |
| 3074F |
|
13,730 |
12,254 |
$538.04 |
| 3078F |
|
15,223 |
13,637 |
$525.04 |
| 99406 |
|
106 |
99 |
$524.96 |
| 99397 |
|
25 |
25 |
$452.75 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
112 |
85 |
$443.76 |
| 3079F |
|
8,882 |
8,172 |
$375.00 |
| 77080 |
|
24 |
24 |
$308.97 |
| 3077F |
|
7,550 |
6,811 |
$297.00 |
| 94060 |
|
12 |
12 |
$268.80 |
| 3075F |
|
6,251 |
5,854 |
$260.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
39 |
35 |
$239.79 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
12 |
12 |
$210.00 |
| 94729 |
|
12 |
12 |
$208.05 |
| 94726 |
|
12 |
12 |
$203.02 |
| 85610 |
|
201 |
175 |
$198.80 |
| 3080F |
|
3,179 |
2,861 |
$163.00 |
| 99490 |
Ccm add 20min |
73 |
63 |
$109.31 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
148 |
139 |
$75.93 |
| 3044F |
|
1,929 |
1,789 |
$65.00 |
| G0269 |
Placement of occlusive device into either a venous or arterial access site, post surgical or interventional procedure (e.g., angioseal plug, vascular plug) |
13 |
13 |
$19.80 |
| 99000 |
|
603 |
563 |
$14.38 |
| 94760 |
|
18 |
17 |
$1.94 |
| G8734 |
Elder maltreatment screen documented as negative, follow-up is not required |
29 |
24 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
92 |
81 |
$0.00 |
| 3017F |
|
30 |
30 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
31 |
25 |
$0.00 |
| 1111F |
|
14 |
12 |
$0.00 |
| 3288F |
|
507 |
431 |
$0.00 |
| G9744 |
Patient not eligible due to active diagnosis of hypertension |
73 |
65 |
$0.00 |
| 3045F |
|
29 |
25 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
25 |
24 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
25 |
24 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
16 |
12 |
$0.00 |